Chrysophanic acid blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway

Phytotherapy Research

Volumn 25, Issue 6, 2011, Pages 833-837

  Lee, Myung Sun ^a   Cha, Eun Young ^a   Sul, Ji Young ^b   Song, In Sang ^b   Kim, Ji Yeon ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

chrysophanic acid; colon cancer; EGFR; mTOR

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CHRYSOPHANIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

MAMMALIA;

EID: 79957873765     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3323     Document Type: Article

References (30)

1. Abraham RT, Gibbons JJ,. 2007. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy. Clin Cancer Res 13: 3109-3114. (Pubitemid 46944891)
2. Aviello G, Rowland I, Gill CI, et al. 2009. Antiproliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells. J Cell Mol Med 14: 2006-2014.
3. Bianco R, Garofalo S, Rosa R, et al. 2008. Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs. Br J Cancer 98: 923-930. (Pubitemid 351341618)
4. Bjornsti MA, Houghton PJ,. 2004. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4: 335-348. (Pubitemid 38579480)
5. Buck E, Eyzaguirre A, Brown E, et al. 2006. Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors. Mol Cancer Ther 5: 2676-2684. (Pubitemid 44848994)
6. Chattopadhyay A, Vecchi M, Ji Q, et al. 1999. The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem 274: 26091-26097.
7. Choi SG, Kim J, Sung ND, et al. 2007. Anthraquinones, Cdc25B phosphatase inhibitors, isolated from the roots of Polygonum multiflorum Thunb. Nat Prod Res 21: 487-493. (Pubitemid 47393737)
8. Dobashi Y, Suzuki S, Sato E, et al. 2009. EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors. Mod Pathol 22: 1328-1340.
9. Dougherty U, Sehdev A, Cerda S, et al. 2008. Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. Clin Cancer Res 14: 2253-2262. (Pubitemid 351559573)
10. Fujishita T, Aoki K, Lane HA, et al. 2008. Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice. Proc Natl Acad Sci USA 105: 13544-13549.
11. Grandis JR, Sok JC,. 2004. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 102: 37-46. (Pubitemid 38429984)
12. Huang Q, Lu G, Shen HM, et al. 2007. Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev 27: 609-630. (Pubitemid 47282446)
13. KÃ¥gedal K, Bironaite D, Ollinger K,. 1999. Anthraquinone cytotoxicity and apoptosis in primary cultures of rat hepatocytes. Free Radic Res 31: 419-428. (Pubitemid 29531122)
14. Kang SC, Lee CM, Choung ES, et al. 2008. Anti-proliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum. Arch Pharm Res 31: 722-726.
15. Lin ML, Lu YC, Chung JG, et al. 2010. Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway. Cancer Lett 291: 46-58.
16. Lu CC, Yang JS, Huang AC, et al. 2010. Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res: in print.
17. Manning BD, Tee AR, Logsdon MN, et al. 2002. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10: 151-162. (Pubitemid 34876569)
18. Meric-Bernstam F, Gonzalez-Angulo AM,. 2009. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27: 2278-2287.
19. Ministry of Health and Welfare and National Cancer Center. 2002. Annual Report of the Korea Central Cancer Registry.
20. Nicholson KM, Anderson NG,. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395. (Pubitemid 34214843)
21. Parkin DM, Bray F, Ferlay J, et al. 2005. Global cancer statistics. CA Cancer J Clin 55: 74-108.
22. Piazzi G, Paterini P, Ceccarelli C, et al. 2006. Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa. Br J Cancer 95: 1525-1528. (Pubitemid 44863355)
23. Radinsky R, Risin S, Fan D, et al. 1995. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1: 19-31.
24. Saito T, Okada S, Ohshima K, et al. 2004. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 145: 4232-4243. (Pubitemid 39120572)
25. Salomon DS, Brandt R, Ciardiello F, et al. 1995. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183-232.
26. Sanoff HK, Sargent DJ, Campbell ME, et al. 2008. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 26: 5721-5727.
27. Su YT, Chang HL, Shyue SK, et al. 2005. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70: 229-241.
28. Ueno Y, Umemori K, Niimi E, et al. 1995. Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukemia cells. Nat Toxins 3: 129-137.
29. Yarden Y, Sliwkowski MX,. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137. (Pubitemid 33674041)
30. Zhang YJ, Dai Q, Sun DF, et al. 2009. mTOR signaling pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol 16: 2617-2628.